Navigation Links
X-Chem and Roche Enter Into Drug Discovery Collaboration and License Agreement
Date:7/1/2010

WALTHAM, Mass., July 1 /PRNewswire/ -- X-Chem, Inc. today announced the signing of a multi-year collaborative agreement with Roche to apply X-Chem's proprietary platform to the rapid discovery of drug candidates against several of Roche's high-value therapeutic targets. As part of the agreement, Roche will provide X-Chem  with upfront and research payments, success-based discovery milestones, and technology access fees. Roche will have the right to develop and commercialise any product arising from the collaboration, and X-Chem will receive development milestones and royalties based on worldwide sales of the therapeutic products developed by Roche.  Financial terms were not disclosed.

"Entering into our first major alliance with a partner such as Roche is extraordinarily exciting for our company," said Richard W. Wagner, Ph.D., President and CEO of X-Chem.  "Roche has an exceptional track record in recognizing and embracing powerful biotechnology innovations.  The program that we are developing will establish drug discovery capabilities unique in the industry."  

About X-Chem.  X-Chem, Inc. is a biotechnology company formed in January 2010 by Richard Wagner, Brant Binder, and Gordon Binder, based in Cambridge, MA.  The company's mission is to apply its innovative drug discovery capabilities to the discovery of compounds against novel, proprietary therapeutic targets.  X-Chem's initial interest is to screen novel targets in stem cell biology using the recently introduced BIND® Scanner instrument developed and marketed by SRU Biosystems, a label-free, microplate-based system for profiling compounds that affect stem cell growth, health, and differentiation.

www.x-chemrx.com


'/>"/>
SOURCE X-Chem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
2. Roche Extends Tender Offer for Ventana
3. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
4. Roche Real-Time HIV Test is Faster and Less Labor-Intensive Than Competitors
5. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
6. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
7. Med Ad News Honors Roche as Company of the Year
8. MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City
9. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
10. Phase I Results Announced for R1507 From Genmabs Collaboration With Roche
11. Kosan to Reacquire Epothilone Program From Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... August 21, 2017 , ... ... Big Island of Hawaii, is pleased to announce the first Delos Wellness Signature™ ... MacArthur Sotheby’s International Realty is working together with listing agent Kelly Allen, R(S) ...
(Date:8/21/2017)... , ... August 21, 2017 , ... ... is utilizing its extensive experience with Health Economics and Outcomes Research (HEOR) and ... Record data. In 2014, US healthcare spending exceeded $3.0 trillion with nearly 1/3 ...
(Date:8/18/2017)... ... August 18, 2017 , ... Producers of the ... Hybrids, Inc. in an upcoming episode, scheduled to broadcast fourth quarter 2017. American ... Federal Hybrids, the independent, family-owned seed company. Educating audiences about its broad portfolio ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... cancer research and personalized medicine, today announced the launch of a new breast ... Missouri. The study’s goal is to evaluate the potential for early detection of ...
Breaking Biology Technology:
(Date:6/14/2017)... 15, 2017  IBM (NYSE: IBM ) is introducing several ... dedicated to developing collaboration between startups and global businesses, taking ... During the event, nine startups will showcase the solutions they ... industries. France is ... with a 30 percent increase in the number of startups ...
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
Breaking Biology News(10 mins):